Genotypes and metallo-beta-lactamases carriage in carbapenem-resistant Pseudomonas aeruginosa isolated from children in Moscow

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):370-374

​ Savinova T.A., Lazareva A.V., Shamina O.V., Kryzhanovskaya O.A., Chebotar I.V., Mayansky N.A.
10.36488/cmac.2018.4.370-374
Pseudomonas aeruginosa antibiotic resistance carbapenems metallo-beta-lactamases MLST
Section
Antimicrobial Resistance
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):370-374

Objective.

To characterize the population structure and determine the genetic mechanisms of carbapenem resistance in nosocomial isolates of P. aeruginosa collected in Moscow in 2012-2016.

Materials and methods.

Carbapenem-resistant isolates were collected in two pediatric hospitals in Moscow. Antibiotics susceptibility of P. aeruginosa isolates was assessed using the E-tests and disk-diffusion method. Multilocus sequence typing (MLST) was used for genotyping of the isolates. The presence of metallo-betalactamase (MBL) genes was determined using real-time PCR.

Results.

All isolates had multidrug resistant phenotype. MLST identified 21 unique sequence types (ST). Five sequence types (ST111, ST235, ST446, ST654 and ST2592) prevailed in the population structure, composing 78% of the carbapenem resistant P. aeruginosa. 50 (57%) isolates carried blaVIM-2 gene; the presence of other carbapenemase genes, including blaNDM and blaIMP, was not detected.

Conclusions.

The genetic structure of carbapenem-resistant P. aeruginosa population is characterized by a diversity of unrelated sequence-types with the predominance of a small number of the high epidemic risk international clones: ST654, ST111 and ST235. The main carbapenem resistance mechanism of P. aeruginosa isolates was the production of VIM-2 carbapenemase.

Tatiana A. Savinova

National Medical Research Center of Children’s Health, Moscow, Russia

Lazareva A.V.

National Medical Research Center of Children’s Health, Moscow, Russia

Shamina O.V.

National Medical Research Center of Children’s Health, Moscow, Russia

Kryzhanovskaya O.A.

National Medical Research Center of Children’s Health, Moscow, Russia

Igor V. Chebotar

National Medical Research Center of Children’s Health, Moscow, Russia

Nikolay A. Mayansky

National Medical Research Center of Children’s Health, Moscow, Russia

  • 1. Kozlov R.S., Golub A.V., Dekhnich A.V., SMART Study Group. Antimicrobial Resistance of Gram-negative Microorganisms Causing Complicated Intraabdominal Infections in Russia. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2015;17(3):227-234. Russian.
  • 2. Breidenstein E.B., de la Fuente-Nunez C., Hancock R.E. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19(8):419-426.
  • 3. Chebotar I.V., Bocharova Yu.A., Mayansky N.A. Mechanisms and regulation of antimicrobial resistance in Pseudomonas aeruginosa. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2017;19(4):308-319. Russian.
  • 4. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Available at: www.eucast.org.
  • 5. Clinical recommendations. Determination of the susceptibility of microorganisms to antimicrobials, 2017. Available at: www.antibiotic. ru/minzdrav/files/docs/clrec-dsma2017. Russian.
  • 6. Pseudomonas aeruginosa MLST Database [database online]. Available at: https://pubmlst.org/paeruginosa.
  • 7. Shibata N., Doi Y., Yamane K., et al. PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol. 2003;41(12):5407-5413.
  • 8. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011;35(5):736-755.
  • 9. Wright L.L., Turton J.F., Livermore D.M., Hopkins K.L.,Woodford N. Dominance of international ‘high-risk clones’ among metallo-βlactamase-producing Pseudomonas aeruginosa in the UK. J Antimicrob Chemother. 2015;70(1):103-1
  • 10. Pobiega M., Maciąg J., Chmielarczyk A. Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa strains isolated from patients with urinary tract infections in Southern Poland. Diagn Microbiol Infect Dis. 2015;83(3):295-297.
  • 11. Rojo-Bezares B., Cavalié L., Dubois D., et al. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital. J Med Microbiol. 2016;65(4):311-319.
  • 12. Pasteran F., Faccone D., Gomez S., et al. Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J Antimicrob Chemother. 2012;67(5):1291-1293.
  • 13. Koh T.H., Khoo C.T., Tan T.T., et al. Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-beta-lactamase genes, including the novel bla(IMP-26) gene. J Clin Microbiol. 2010;48(7):2563-2564.
  • 14. Samuelsen O., Toleman M.A., Sundsfjord A., et al. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother. 2010;54(1):346-352.
  • 15. Mataseje L.F., Peirano G., Church D.L., et al. Colistin-Nonsusceptible Pseudomonas aeruginosa Sequence Type 654 with blaNDM-1 Arrives in North America. Antimicrob Agents Chemother. 2016;60(3):17941800.
  • 16. Hrabák J., Cervená D., Izdebski R., et al. Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-βlactamase in Central Europe. J Clin Microbiol. 2011;49(1):474-475.
  • 17. Hammerum A.M., Jakobsen L., Hansen F., et al. Characterisation of an IMP-7-producing ST357 Pseudomonas aeruginosa isolate detected in Denmark using whole genome sequencing. Int J Antimicrob Agents. 2015;45(2):200-201.
  • 18. Ji J., Wang J., Zhou Z., et al. Multilocus sequence typing reveals genetic diversity of carbapenem- or ceftazidime-nonsusceptible Pseudomonas aeruginosa in China. Antimicrob Agents Chemother. 2013;57(11):5697-5700.
  • 19. Mano Y., Saga T., Ishii Y., et al. Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan. BMC Microbiol. 2015;15:41.
  • 20. Papagiannitsis C.C., Medvecky M., Chudejova K., et al. Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-βLactamase. Antimicrob Agents Chemother. 2017;61(12):e01811-17.
  • 21. Avetisyan L.R., Voronina O.L., Chernuha M.Yu., et al. Persistence of Pseudomonas aeruginosa strains in patients of the Federal Research Center of Transplantology and Artificial Organs. Zhurnal mikrobiologii, jepidemiologii i immunobiologii. 2010;4:99-104. Russian.
  • 22. Treepong P., Kos V.N., Guyeux C., et al. Global emergence of the widespread Pseudomonas aeruginosa ST235 clone. Clin Microbiol Infect. 2018;24(3):258-266.
  • 23. Edelstein M.V., Skleenova E.N., Shevchenko O.V., et al. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Lancet Infect Dis. 2013;13(10):867-876.
  • 24. Pirnay J.P., De Vos D., Cochez C., et al. Pseudomonas aeruginosa displays an epidemic population structure. Environ Microbiol. 2002;4(12):898-911.
  • 25. Mayanskiy N., Chebotar I., Alyabieva N., et al. Emergence of the Uncommon Clone ST944/ST78 Carrying blaOXA-40-like and blaCTX-M-like Genes Among Carbapenem-Nonsusceptible Acinetobacter baumannii in Moscow, Russia. Microb Drug Resist. 2017;23(7):864-870.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared